Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 109401-109450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05685810
Genetic Determinants of Kidney Disease in People of African Ancestry With HIV
N/AActive, not recruiting
3,029 participants
Started: May 1, 2018 · Completed: Jan 31, 2030
7 conditions23 sponsors1 location
NCT03522831
CF Bronchodilation
NAActive, not recruiting
20 participants
Started: May 1, 2018 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT03587922
FANTOM Post Market Clinical Trial
NARecruiting
1,500 participants
Started: May 1, 2018 · Completed: May 1, 2025
1 condition1 sponsor10 locations
NCT03541512
Remote Mindfulness Education PLV
NAEnrolling by invitation
46 participants
Started: May 1, 2018 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT03708952
Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic Diseases
N/AActive, not recruiting
25,000 participants
Started: May 1, 2018 · Completed: May 1, 2028
2 conditions3 sponsors2 locations
NCT03368313
Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis
NARecruiting
120 participants
Started: May 1, 2018 · Completed: Nov 30, 2025
2 conditions1 sponsor18 locations
NCT03278119
Sleep Aging and Risk for Alzheimer's 2.0
N/AActive, not recruiting
158 participants
Started: May 1, 2018 · Completed: Dec 25, 2025
2 conditions2 sponsors1 location
NCT03539575
CB1R in Synthetic Psychoactive Cannabinoids
NAActive, not recruiting
15 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT03745521
Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners
N/AActive, not recruiting
226 participants
Started: May 1, 2018 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT03346694
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
NARecruiting
660 participants
Started: May 1, 2018 · Completed: May 1, 2035
1 condition1 sponsor1 location
NCT03860558
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
NARecruiting
40 participants
Started: May 1, 2018 · Completed: Jul 1, 2025
3 conditions1 sponsor1 location
NCT03422393
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
PHASE1Active, not recruiting
24 participants
Started: May 1, 2018 · Completed: Aug 31, 2028
2 conditions2 sponsors1 location
NCT05764434
ALS Spinal Cord Gray and White Matter Study
N/ARecruiting
80 participants
Started: May 1, 2018 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT02645266
Mean Visual Acuity Changes Following Five Injections of Aflibercept
NAActive, not recruiting
48 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03860857
Biomarker Exploration in Aging, Cognition and Neurodegeneration
PHASE3Recruiting
300 participants
Started: May 1, 2018 · Completed: Dec 22, 2027
3 conditions2 sponsors1 location
NCT03337932
Duration of Doxycycline Treatment in MEM Patients
NARecruiting
200 participants
Started: May 1, 2018 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT04263298
Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
PHASE3Recruiting
210 participants
Started: May 1, 2018 · Completed: May 1, 2030
1 condition1 sponsor13 locations
NCT05461820
Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
PHASE4Recruiting
240 participants
Started: May 1, 2018 · Completed: Jul 31, 2030
4 conditions1 sponsor1 location
NCT03711617
Uremic Toxins and Outcomes in Chronic Kidney Disease
N/ARecruiting
500 participants
Started: May 1, 2018 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03834844
Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF)
NAActive, not recruiting
50 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03400085
Pilot Study of an mHealth Intervention for Living Donor Follow-up
NAActive, not recruiting
400 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
3 conditions4 sponsors2 locations
NCT04619524
Biomarkers of Endometrial Receptivity
NARecruiting
476 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
4 conditions3 sponsors3 locations
NCT03820310
Clinical Trial of Autologous Tcm Immunotherapy in ICC
PHASE2Recruiting
20 participants
Started: May 1, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05679336
Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy
NARecruiting
40 participants
Started: May 1, 2018 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT03507257
Longitudinal Early-onset Alzheimer's Disease Study Protocol
N/ARecruiting
850 participants
Started: Apr 30, 2018 · Completed: May 31, 2026
3 conditions4 sponsors23 locations
NCT03523312
Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer
PHASE2Active, not recruiting
47 participants
Started: Apr 30, 2018 · Completed: Apr 30, 2026
1 condition1 sponsor8 locations
NCT03057054
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
PHASE3Active, not recruiting
173 participants
Started: Apr 30, 2018 · Completed: Jun 30, 2026
4 conditions2 sponsors43 locations
NCT03207945
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study)
PHASE3Recruiting
140 participants
Started: Apr 30, 2018 · Completed: Aug 31, 2026
3 conditions2 sponsors1 location
NCT04207931
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
PHASE4Recruiting
250 participants
Started: Apr 30, 2018 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT03796078
Maxillomandibular Advancement in the Treatment of Obstructive Sleep Apnea
NARecruiting
80 participants
Started: Apr 30, 2018 · Completed: Dec 1, 2025
4 conditions1 sponsor1 location
NCT03282305
Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese
N/ANot yet recruiting
5,000 participants
Started: Apr 30, 2018 · Completed: Dec 31, 2029
2 conditions3 sponsors0 locations
NCT03419481
Pembrolizumab in Hepatocellular Carcinoma
PHASE2Active, not recruiting
30 participants
Started: Apr 30, 2018 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT03355976
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
PHASE2Active, not recruiting
46 participants
Started: Apr 30, 2018 · Completed: Mar 31, 2026
5 conditions5 sponsors4 locations
NCT04273880
Differences by Sex and Genotype in the Effects of Stress on Executive Functions
PHASE1Recruiting
146 participants
Started: Apr 28, 2018 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT03449108
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
PHASE2Active, not recruiting
30 participants
Started: Apr 27, 2018 · Completed: Apr 30, 2027
16 conditions3 sponsors1 location
NCT03412435
Asan Medical Center Myocardial Infarction Registry
N/ARecruiting
5,000 participants
Started: Apr 27, 2018 · Completed: Dec 31, 2030
2 conditions2 sponsors1 location
NCT03569241
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases
PHASE2Active, not recruiting
196 participants
Started: Apr 27, 2018 · Completed: Dec 31, 2026
4 conditions2 sponsors29 locations
NCT03523377
Overnight Fasting After Completion of Therapy: The OnFACT Study
NAActive, not recruiting
28 participants
Started: Apr 27, 2018 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT04288323
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) Vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients with Cirrhosis
PHASE4Recruiting
150 participants
Started: Apr 27, 2018 · Completed: Dec 30, 2025
3 conditions3 sponsors1 location
NCT03389477
Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
PHASE2Active, not recruiting
26 participants
Started: Apr 27, 2018 · Completed: Apr 6, 2027
1 condition2 sponsors1 location
NCT03535831
PSMA PET Registry (18F-DCFPyL)
NAActive, not recruiting
200 participants
Started: Apr 27, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03258567
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
PHASE2Recruiting
40 participants
Started: Apr 26, 2018 · Completed: Jun 1, 2031
4 conditions1 sponsor1 location
NCT03419234
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
PHASE2Active, not recruiting
223 participants
Started: Apr 26, 2018 · Completed: Apr 1, 2026
5 conditions2 sponsors672 locations
NCT06968923
Effectiveness of a Home-Based Rehabilitation Program in Stroke Survivors Using the Euleria Home® Device
NARecruiting
90 participants
Started: Apr 26, 2018 · Completed: Apr 30, 2026
4 conditions1 sponsor1 location
NCT06041906
International Registry of Congenital Portosystemic Shunt (IRCPSS)
N/AEnrolling by invitation
500 participants
Started: Apr 26, 2018 · Completed: Dec 31, 2028
2 conditions4 sponsors26 locations
NCT03282409
Prediction of Chronic Renal Disease After Acute Kidney Injury in the Intensive Care Unit
N/AActive, not recruiting
425 participants
Started: Apr 26, 2018 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT03530826
A Crowd Sourcing Platform for Patients With Cancer
N/ARecruiting
5,000 participants
Started: Apr 26, 2018 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT03524430
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
NARecruiting
801 participants
Started: Apr 26, 2018 · Completed: Mar 31, 2031
1 condition1 sponsor7 locations
NCT03519997
A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma
PHASE2Active, not recruiting
35 participants
Started: Apr 26, 2018 · Completed: Apr 1, 2026
1 condition2 sponsors1 location
NCT03548571
Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy
PHASE2/PHASE3Recruiting
60 participants
Started: Apr 26, 2018 · Completed: May 1, 2026
1 condition1 sponsor1 location